No image available

Eoin O'Connell

Principal Data Scientist

Email

eoin.oconnell@aoshearman.com

Phone

+44 28 9060 7016

Offices

Belfast

V-CARD
Eoin has worked as a data scientist, consultant, and statistician in a range of industries.

Prior to joining the firm, he was at the Department of Justice & Equality in Ireland providing high-level civil servants with insights on the flow of people through the criminal justice system.

Before that, he was a researcher alongside cardiologists across several hospitals in Dublin, quantifying risk factors and prognoses for patients with cardiovascular disease. He has also worked in the fields of chemical exposure modelling, nutrition & physical exercise, financial services, and consulted on many standalone research and engineering projects – from diagnosing pneumonia in Malawian infants to monitoring stock for a Spanish clothing conglomerate. He joined the firm in 2019 and works with lawyers across our practice groups, using data science techniques to increase the efficiency through which we deliver client projects, typically managing the large-scale extraction, processing, enrichment, and summarisation of data, as well as providing expert advice on technical issues.

Published Work

  • Arundell, L, Salmon, J, Veitch, J, O’Connell, E, et al. Standardising the ‘after-school’ period for children’s physical activity and sedentary behaviour. Health Promotion Journal of Australia, 2013
  • Bermingham, M, Shanahan, MK, O’Connell, E, et al. Aspirin Use In Heart Failure: Is Low Dose Therapy Associated With Mortality And Morbidity Benefits In A Large Community Population? Circulation: Heart Failure, 2014
  • Hinkley, T, O’Connell, E, Okely, T, et al. Assessing volume of accelerometry data for reliability in preschool children. Medicine & Science in Sports and Exercise, 2012
  • Hume, C, Salmon, J, Veitch, J, O’Connell, E, et al. Socio-demographic characteristics of children experiencing socioeconomic disadvantage who meet physical activity and screen-time recommendations: The READI study. Preventive Medicine, 2011
  • Ledwidge, M, Gallagher, J, Conlon, C, Tallon, E, O’Connell, E, et al. Natriuretic Peptide-Based Screening and Collaborative Care for Heart Failure: The STOP-HF Randomized Trial. The Journal of the American Medical Association, 2013
  • McClelland, S, Zhou, S, O’Connell, E, et al. New-onset heart failure in the STOP-HF programme. Natriuretic peptide defines and tracks risk and enables earlier diagnosis of heart failure. European Journal of Heart Failure, 2020
  • McDonald, K, Glezeva, N, Collier, P, O’Reilly, J, O’Connell, E, et al. Tetranectin, a potential novel diagnostic biomarker of heart failure, is expressed within the myocardium and associates with cardiac fibrosis. Scientific Reports, 2020
  • O’Connell, E. Various articles in: Greenwald, SJ & Thomley, JE (Eds.) The Encyclopedia of Mathematics and Society, 2011
  • Pharithi, RB, Ferre-Vallverdu, M, Maisel, AS, O'Connell, E, et al. Sacubitril-Valsartan in a routine community population: attention to volume status critical to achieving target dose. European Society of Cardiology: Heart Failure, 2020
  • Ridgers, ND, Salmon, J, Ridley, K, O’Connell, E, et al. Agreement between activPAL and ActiGraph for assessing children’s sedentary time. International Journal of Behavioral Nutrition and Physical Activity, 2012
  • Watson, CJ, James, S. O’Connell, E, et al. Influence of diabetes on natriuretic peptide thresholds in screening for Stage B heart failure. Biomarkers, 2016
  • Watson, CJ, Tea, I, O'Connell, E, et al. Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community. Journal of Cellular and Molecular Medicine, 2020

Qualifications

Academic

Certificate in Financial Mathematics, Institute and Faculty of Actuaries, 2014

MLitt in Experimental Psychology awarded with distinction, University College Dublin, 2005

BA(Hons.) in Psychology, University College Dublin, 2003

Disclaimer
A&O Shearman was formed on May 1, 2024 by the combination of Shearman & Sterling LLP and Allen & Overy LLP and their respective affiliates (the legacy firms). Any matters referred to above may include matters undertaken by one or more of the legacy firms rather than A&O Shearman.